サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1210171

HER2阻害薬の世界市場レポート 2023年

HER2 Inhibitors Global Market Report 2023
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.88円
HER2阻害薬の世界市場レポート 2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

HER2阻害薬の世界市場は、2021年の66億1000万米ドルから2022年には72億6000万米ドルへ、年平均成長率（CAGR）9.9％で成長すると予測されています。ロシア・ウクライナ戦争は、少なくとも短期的には、COVID-19の大流行から世界経済が回復する可能性を混乱させました。この2国間の戦争は、複数の国に対する経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を及ぼしています。HER2阻害薬市場は、2026年にはCAGR9.9%で106億米ドルに達すると予想されています。

2022年のHER2阻害薬市場では、北米が最大の地域となりました。中東は予測期間中、最も大きく成長する地域と予想されます。HER2阻害薬市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 HER2阻害薬市場の特徴

第3章 HER2阻害薬の市場動向と戦略

第4章 HER2阻害薬市場- マクロ経済シナリオ

  • COVID-19が市場に与える影響
  • ウクライナ・ロシアの戦争が市場に与える影響
  • 高インフレが市場に与える影響

第5章 HER2阻害薬の市場規模と成長

  • 世界のHER2阻害薬市場の実績、2017年から2022年
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のHER2阻害薬市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 HER2阻害薬市場セグメンテーション

  • 世界のHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 単剤療法
  • 併用療法
  • 世界のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 扁平上皮がん
  • 腺がん
  • 大細胞がん
  • 乳がん
  • その他の用途
  • 世界のHER2阻害薬市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 病院
  • 診療所
  • その他のエンドユーザー

第7章 HER2阻害薬市場の地域および国の分析

  • 世界のHER2阻害薬市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界のHER2阻害薬市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋のHER2阻害薬市場

  • アジア太平洋HER2阻害薬市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋のHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アジア太平洋のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国のHER2阻害薬市場

  • 中国HER2阻害薬市場概要
  • 中国HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国HER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドのHER2阻害薬市場

  • インドHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドのHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本のHER2阻害薬市場

  • 日本のHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアのHER2阻害薬市場

  • オーストラリアHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアのHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアのHER2阻害薬市場

  • インドネシアのHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアのHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国のHER2阻害薬市場

  • 韓国HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧のHER2阻害薬市場

  • 西欧のHER2阻害薬市場概要
  • 西欧HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国のHER2阻害薬市場

  • 英国HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツのHER2阻害薬市場

  • ドイツHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスのHER2阻害薬市場

  • フランスHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧のHER2阻害薬市場

  • 東欧のHER2阻害薬市場概要
  • 東欧HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアのHER2阻害薬市場

  • ロシアHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアのHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米のHER2阻害薬市場

  • 北米HER2阻害薬市場概要
  • 北米HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米HER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国のHER2阻害薬市場

  • 米国HER2阻害薬市場概要
  • 米国HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国HER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米のHER2阻害薬市場

  • 南米HER2阻害薬市場概要
  • 南米HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米のHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルのHER2阻害薬市場

  • ブラジルHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルのHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東のHER2阻害薬市場

  • 中東HER2阻害薬市場概要
  • 中東HER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東HER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカのHER2阻害薬市場

  • アフリカHER2阻害薬市場概要
  • アフリカHER2阻害薬市場、治療別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカHER2阻害薬市場、用途別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 HER2阻害薬市場の競合情勢と企業プロファイル

  • HER2阻害薬市場の競合情勢
  • HER2阻害薬市場の企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Puma Biotechnology Inc.

第28章 HER2阻害薬パイプライン分析

第29章 HER2阻害薬市場における主要な合併と買収

第30章 HER2阻害薬市場の将来の見通しと潜在的な分析

第31章 付録

目次
Product Code: r2024

“HER2 Inhibitors Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on her2 inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for her2 inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The her2 inhibitors market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment: Monotherapy; Combination Therapy

2) By Application: Squamous Cell Carcinoma; Adenocarcinoma; Large Cell Carcinoma; Breast Cancer; Other Applications

3) By End User: Hospitals; Clinics; Other End Users

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Pfizer Inc.; Puma Biotechnology Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the HER2 inhibitors market are: F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan and Biocon.

The global her2 inhibitors market is expected to grow from $6.61 billion in 2021 to $7.26 billion in 2022 at a compound annual growth rate (CAGR) of 9.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The HER2 inhibitors market is expected to reach $10.60 billion in 2026 at a CAGR of 9.9%.

The HER2 inhibitors market consists of sales of lapatinib, neratinib, tucatinib, and pyrotinib. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

HER2 inhibitors refer to a group of drugs used to treat certain HER2-low breast malignancies as well as all stages of HER2-positive breast cancer, from early-stage to metastatic. Anti-HER2 drugs bind to the HER2 receptor proteins on the surface of breast cancer cells, and they function by preventing the HER2 receptors in HER2-positive breast cancer from receiving growth impulses.

North America was the largest region in the HER2 inhibitors market in 2022. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the HER2 inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of treatments for HER2 inhibitors are monotherapy and combination therapy. Monotherapy refers to the use of single medicine to treat a specific condition or disease. The different applications include squamous cell carcinoma, adenocarcinoma, large cell carcinoma, breast cancer, and others and involve several sectors such as hospitals, clinics, and others.

The rise in the number of breast cancer cases across the globe is likely to contribute to the growth of the HER-2 inhibitors market during the forecast period. According to the American Cancer Society, as of January 2020, there were more than 3.5 million women with a history of breast cancer in the US. This includes women currently being treated and women who have completed their treatment. According to the World Health Organization (WHO), breast cancer affected 2.3 million women globally in 2020, with 685 000 fatalities. Therefore, the rise in the breast cancer incidence rate globally is anticipated to boost the demand for the HER-2 inhibitors market over the forthcoming years.

High costs associated with the HER-2 inhibitors treatment are a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. Trastuzumab, a licensed HER2 inhibitor, has been the most expensive systemic cancer therapy procedure at a variety of disease sites. The cost of trastuzumab in India ranged from $774.6 to $841.35 per 440 mg vial. In patients with HER 2 positive early breast cancer, nearly 18 cycles of therapy based on trastuzumab are needed which further charges more than $1,335.52 in India. Therefore, the high cost of HER2 inhibitors is expected to hinder the growth of the HER2 inhibitors market.

Biotechnology companies are focusing on acquiring or partnering with biopharmaceutical companies to develop and promote the HER-2 inhibitors market. There have been several partnerships in recent years which help these companies to increase their HER-2 inhibitors portfolio, enhance their revenues and share the costs. For instance, in June 2020, Alphamab Oncology, a biotechnology company, collaborated with Sanofi, a pharmaceutical company, for investigating KN026 in combination with other drugs for the treatment of HER2 breast cancer. KN026 is a HER2 inhibitor developed by Alphamab Oncology.

In August 2021, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation acquired Trillium Therapeutics Inc for an undisclosed amount. This acquisition of Trillium will build a robust record of leadership in oncology, enhancing the hematology portfolio to enhance outcomes for people living with blood cancers worldwide. Trillium Therapeutics Inc is a Canada-based company that develops therapies for the treatment of cancer.

The countries covered in the HER2 inhibitors market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The HER2 inhibitors market research report is one of a series of new reports from The Business Research Company that provides HER2 inhibitors market statistics, including HER2 inhibitors industry global market size, regional shares, competitors with a HER2 inhibitors market share, detailed HER2 inhibitors market segments, market trends and opportunities, and any further data you may need to thrive in the HER2 inhibitors industry. This HER2 inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. HER2 Inhibitors Market Characteristics

3. HER2 Inhibitors Market Trends And Strategies

4. HER2 Inhibitors Market - Macro Economic Scenario

4.1 COVID-19 Impact On HER2 Inhibitors Market

4.2 Ukraine-Russia War Impact On HER2 Inhibitors Market

4.3 Impact Of High Inflation On HER2 Inhibitors Market

5. HER2 Inhibitors Market Size And Growth

  • 5.1. Global HER2 Inhibitors Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global HER2 Inhibitors Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. HER2 Inhibitors Market Segmentation

  • 6.1. Global HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Monotherapy
  • Combination Therapy
  • 6.2. Global HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Large Cell Carcinoma
  • Breast Cancer
  • Other Applications
  • 6.3. Global HER2 Inhibitors Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Clinics
  • Other End Users

7. HER2 Inhibitors Market Regional And Country Analysis

  • 7.1. Global HER2 Inhibitors Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global HER2 Inhibitors Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific HER2 Inhibitors Market

  • 8.1. Asia-Pacific HER2 Inhibitors Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China HER2 Inhibitors Market

  • 9.1. China HER2 Inhibitors Market Overview
  • 9.2. China HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India HER2 Inhibitors Market

  • 10.1. India HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan HER2 Inhibitors Market

  • 11.1. Japan HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia HER2 Inhibitors Market

  • 12.1. Australia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia HER2 Inhibitors Market

  • 13.1. Indonesia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea HER2 Inhibitors Market

  • 14.1. South Korea HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe HER2 Inhibitors Market

  • 15.1. Western Europe HER2 Inhibitors Market Overview
  • 15.2. Western Europe HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK HER2 Inhibitors Market

  • 16.1. UK HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany HER2 Inhibitors Market

  • 17.1. Germany HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France HER2 Inhibitors Market

  • 18.1. France HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe HER2 Inhibitors Market

  • 19.1. Eastern Europe HER2 Inhibitors Market Overview
  • 19.2. Eastern Europe HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia HER2 Inhibitors Market

  • 20.1. Russia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America HER2 Inhibitors Market

  • 21.1. North America HER2 Inhibitors Market Overview
  • 21.2. North America HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA HER2 Inhibitors Market

  • 22.1. USA HER2 Inhibitors Market Overview
  • 22.2. USA HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America HER2 Inhibitors Market

  • 23.1. South America HER2 Inhibitors Market Overview
  • 23.2. South America HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil HER2 Inhibitors Market

  • 24.1. Brazil HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East HER2 Inhibitors Market

  • 25.1. Middle East HER2 Inhibitors Market Overview
  • 25.2. Middle East HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa HER2 Inhibitors Market

  • 26.1. Africa HER2 Inhibitors Market Overview
  • 26.2. Africa HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. HER2 Inhibitors Market Competitive Landscape And Company Profiles

  • 27.1. HER2 Inhibitors Market Competitive Landscape
  • 27.2. HER2 Inhibitors Market Company Profiles
    • 27.2.1. F. Hoffmann-La Roche Ltd.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck & Co. Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis AG
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Pfizer Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Puma Biotechnology Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. HER2 Inhibitors Pipeline Analysis

29. Key Mergers And Acquisitions In The HER2 Inhibitors Market

30. HER2 Inhibitors Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Historic And Forecast Inflation Rates
  • 31.4. Research Inquiries
  • 31.5. The Business Research Company
  • 31.6. Copyright And Disclaimer